CANSEEK Trademark

Trademark Overview

On Sunday, November 1, 2020, a trademark application was filed for CANSEEK with the United States Patent and Trademark Office. The USPTO has given the CANSEEK trademark a serial number of 90291713. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 12, 2024. This trademark is owned by Point Biopharma Inc.. The CANSEEK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical products used in the field of nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
canseek

General Information

Serial Number90291713
Word MarkCANSEEK
Filing DateSunday, November 1, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 11, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical products used in the field of nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, December 27, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePoint Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M4T2S3
CA
Party NamePoint Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46268

Trademark Events

Event DateEvent Description
Wednesday, November 4, 2020NEW APPLICATION ENTERED
Sunday, December 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 5, 2021ASSIGNED TO EXAMINER
Tuesday, April 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 11, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 11, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 6, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 8, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, December 8, 2021SOU EXTENSION 1 FILED
Wednesday, December 8, 2021SOU EXTENSION 1 GRANTED
Friday, December 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 7, 2022PETITION TO REVIVE-GRANTED
Tuesday, June 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 6, 2022SOU EXTENSION 2 FILED
Friday, August 5, 2022SOU EXTENSION 2 GRANTED
Thursday, July 7, 2022TEAS PETITION TO REVIVE RECEIVED
Thursday, July 7, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, July 7, 2022NOTICE OF REVIVAL - E-MAILED
Thursday, August 4, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 8, 2024SOU TEAS EXTENSION RECEIVED
Monday, January 8, 2024SOU EXTENSION 5 FILED
Saturday, August 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 6, 2023SOU TEAS EXTENSION RECEIVED
Friday, January 6, 2023SOU EXTENSION 3 FILED
Friday, January 6, 2023SOU EXTENSION 3 GRANTED
Thursday, July 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 6, 2023SOU EXTENSION 4 FILED
Thursday, July 6, 2023SOU EXTENSION 4 GRANTED
Saturday, July 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 12, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, August 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, March 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 12, 2024SOU EXTENSION 5 GRANTED
Saturday, January 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

canseek pharmaceutical treatment diagnosis delivery preparations agents imaging consisting drug facilitate